Key result
This review highlights recent progress on the regulation of EAG1 channels by endogenous signals and their potential functions in normal neuronal signaling and neurological diseases.
This review highlights the emerging importance of EAG1 potassium channels in neuronal signaling and neurological diseases, expanding beyond their established role in oncology.
EAG1 channels may inform neurological disease mechanisms; leaves open therapeutic targeting pending targeted clinical studies.
Ether-à-go-go1 (Eag1, Kv10.1, KCNH1) K+ channel is a member of the voltage‐gated K+ channel family mainly distributed in the central nervous system and cancer cells. Like other types of voltage‐gated K+ channels, the EAG1 channels are regulated by a variety of endogenous signals including reactive oxygen species, rendering the EAG1 to be in the redox‐regulated ion channel family. The role of EAG1 channels in tumor development and its therapeutic significance have been well established. Meanwhile, the importance of hEAG1 channels in the nervous system is now increasingly appreciated. The present review will focus on the recent progress on the channel regulation by endogenous signals and the potential functions of EAG1 channels in normal neuronal signaling as well as neurological diseases.
No takes yet. Share an insight, caveat, or question.
Han et al. (2017) conducted a review in Neurological diseases. EAG1 channels was evaluated. This review highlights recent progress on the regulation of EAG1 channels by endogenous signals and their potential functions in normal neuronal signaling and neurological diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: